Results 261 to 270 of about 353,600 (336)

Evaluating the Efficiency of Hydroponic and Aeroponic Plant Nutrient Utilization Systems for Growing Tomatoes in Salinized Fishpond Wastewater [PDF]

Manal G. Ibrahim, Yasser M. Awad, Noha A. Mahgoub, Samira Mansour   +3 more
openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Editorial: Diagnostic innovations for microbial pathogens in edible plants: cutting-edge technologies for enhanced detection. [PDF]

Front Microbiol
Kumar R, Roy A, Zhai Y.
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Impact of Plant Part and Age of Allium tuberosum Rottler ex Sprengel on Antioxidant Properties. [PDF]

Molecules
Żurawik A, Wesołowska A, Żurawik P.
europepmc   +1 more source

The current status and prospects of growing plant-based food products in the present conditions of the Ukrainian agricultural sector [PDF]

Natalya Shevchuk
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Non- Conventional Agents Enhance Sweet Pepper (<i>Capsicum annuum</i> L. var. <i>annuum</i>) Defense against <i>Aphis Gossypii</i>, <i>Thrips Tabaci</i>, and Their Predators <i>Chrysoperla Carnea</i> and <i>Orius Insidiosus</i>. [PDF]

Glob Chall
Zayed MS, Hegab MA, SaadAllah MS, Elnabawy EM, El-Beltagi HS, Abo-Ogiala A, El-Harariy A.   +6 more
europepmc   +1 more source

Sceneries of the study area taken by the authors during field visits (a) General landscape view of Tehsil Hasilpur, highlighting the semi-arid environment (b) Wild medicinal flora growing in natural habitats (c) Perennial plant species dominant in the area (d) Field survey with a local informant sharing ethnomedicinal knowledge during data collection (e) A typical household garden where some medicinal plants are cultivated for domestic use (f) Rural household surroundings.

Xiaonan Wang (276308), Yi Zheng (113896), Xin Cui (1610701), Tauseef Anwar (3612392), Huma Qureshi (627459)   +4 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source